Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

机译：新出现的复发/难治性多发性骨髓瘤：Car-T及以后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Mechanisms of action of emerging multiple myeloma therapies

机译：新出现多发性骨髓瘤疗法的作用机制

著录项

期刊名称 Journal of Hematology Oncology
作者
Christopher T. Su; J. Christine Ye;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 18
原文格式 PDF
正文语种
中图分类肿瘤学;血液学检验;
关键词

机译：多发性骨髓瘤;审查;首先在人体试验中;嵌合抗原受体;CAR-T;双特异性抗体;T细胞参录;抗体 - 药物缀合物;单克隆抗体;小分子抑制剂;靶向治疗;

相似文献

外文文献
中文文献
专利

1. Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature [J] . Ying Qian, Zijun Qian, Xiujie Zhao, Frontiers in Medicine . 2021,第a期

机译：用抗BCMA Car-T细胞疗法的复发/难治性髓外骨髓瘤的成功治疗随后是Haploidentical造血干细胞移植：案例报告和对当代文学的审查
2. Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis [J] . Qin Yang, Xin Li, Fangrong Zhang, International Journal of Medical Sciences . 2021,第8期

机译：Car-T治疗复发或难治性多发性骨髓瘤的疗效和安全性：系统审查和荟萃分析
3. Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function [J] . Shao-long HE, Yu-hang CHENG, Di WANG, 当代医学科学(英文) . 2021,第003期

机译：Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
4. Durability of Response with Thalidomide Therapy for Relapsed Multiple Myeloma [C] . B. Myers, S.G. Jones, G. Do I an European Haematology Association . 2002

机译：耐久性耐久性与多发性骨髓瘤复发疗法
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature [O] . Ying Qian, Zijun Qian, Xiujie Zhao, 2021

机译：成功处理复发/难治性髓外骨髓瘤与抗BCMA Car-T细胞疗法其次是Haploidentical造血干细胞移植：案例报告和对当代文学的审查
7. Efficacy and Safety of CAR-T Therapy for Relapse or Refractory Multiple Myeloma: A systematic review and meta-analysis [O] . Qin Yang, Xin Li, Fangrong Zhang, 2021

机译：Car-T治疗复发或难治性多发性骨髓瘤的疗效和安全性：系统审查和荟萃分析

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

摘要

著录项

相似文献

相关主题

期刊订阅